Bombay High Court to Hear COVID-19 Vaccine Death Case

Join The Conversation! | https://trialsitenews.com/
A petitioner in India’s Bombay High Court claims that the COVID-19 vaccine called Covishield killed his daughter and is now seeking compensation for the loss. The claimant argues that his daughter’s death is directly linked to the side effects of Covishield, the viral vector COVID-19 vaccine originally developed by University of Oxford, licensed by AstraZeneca for the Indian subcontinent and other parts of the world, then licensed for production and commercialization to the Serum Institute of India (SII), the world’s busiest vaccine producer. Originally labeled ChAdOx1 nCoV-19, or the Oxford/AstraZeneca vaccine, the U.S. Food and Drug Administration cancelled clinical trials in the U.S. earlier during the pandemic due to safety incidents. India’s drug regulator (Drug Controller General of India) granted emergency authorization for the product at the start of 2021 by SII. TrialSite reported that SII made moves last year lobby the government to remove all liability for these COVID-19 vaccines, much like is the case in the United States with the PREP Act. The claimant has served multiple parties from SII to the Bill Gates Foundation.